IRIS
ORDITURA, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.223
NA - Nord America 3.635
AS - Asia 422
AF - Africa 19
SA - Sud America 14
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 8.330
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.560
IE - Irlanda 1.386
UA - Ucraina 625
IT - Italia 582
GB - Regno Unito 469
DE - Germania 358
FR - Francia 321
CN - Cina 251
FI - Finlandia 159
SE - Svezia 142
GR - Grecia 117
TR - Turchia 89
CA - Canada 70
VN - Vietnam 38
PL - Polonia 30
KR - Corea 22
BE - Belgio 16
SC - Seychelles 13
JP - Giappone 7
EU - Europa 6
NZ - Nuova Zelanda 6
SG - Singapore 6
ES - Italia 5
MX - Messico 5
NL - Olanda 5
AU - Australia 4
BR - Brasile 4
IR - Iran 4
CO - Colombia 3
EG - Egitto 3
PE - Perù 3
CH - Svizzera 2
CL - Cile 2
A1 - Anonimo 1
AL - Albania 1
AR - Argentina 1
IL - Israele 1
IN - India 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
RU - Federazione Russa 1
TH - Thailandia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 8.330
Salva come PNG Salva come JPEG
Città #
Dublin 1.376
Jacksonville 935
Chandler 645
Princeton 190
Medford 172
Caserta 138
Bremen 122
New York 120
Roxbury 120
Ann Arbor 107
Boardman 103
San Mateo 95
Wilmington 76
Woodbridge 59
Naples 57
Elora 52
Nanjing 46
Des Moines 45
Beijing 44
Napoli 41
Dong Ket 36
Cambridge 34
Jinan 31
Kraków 29
Ashburn 25
Mountain View 20
Houston 18
Brussels 15
Norwalk 15
Aiello Del Sabato 14
Helsinki 13
Nanchang 13
Shenyang 11
Auburn Hills 10
Los Angeles 10
Ottawa 10
Changsha 9
Tianjin 9
Düsseldorf 8
Hangzhou 8
Redwood City 8
Milan 7
Ningbo 7
Taizhou 7
Lanzhou 6
Lappeenranta 6
Salerno 6
Shanghai 6
Zhengzhou 6
Guangzhou 5
Hebei 5
Jiaxing 5
Kunming 5
Taiyuan 5
Toronto 5
Battipaglia 4
Boydton 4
Changchun 4
Haikou 4
Marigliano 4
Rome 4
San Nicola la Strada 4
Scottsdale 4
Somma Vesuviana 4
Trieste 4
Arzignano 3
Benevento 3
Bogotá 3
Canicattì 3
Casoria 3
Cattolica 3
Ercolano 3
Frattamaggiore 3
Gunzenhausen 3
Hanover 3
Jesi 3
Lima 3
Maynooth 3
Mugnano Di Napoli 3
Munich 3
Padova 3
Parma 3
Pomezia 3
Singapore 3
Walnut 3
Xiangfen 3
Amsterdam 2
Andover 2
Antea 2
Athens 2
Avellino 2
Bagnoli Irpino 2
Barcelona 2
Bari 2
Buonabitacolo 2
Calvizzano 2
Castellammare di Stabia 2
Catania 2
Fairfield 2
Ferrara 2
Totale 5.101
Salva come PNG Salva come JPEG
Nome #
ONCOLOGIA MEDICA 143
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 99
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 88
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial 85
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: A propensity score-matched analysis 83
Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study. Curr Oncol 21, 3, june 2014 125-133 80
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. 74
Amifostine: a selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review) 73
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 73
Pancreatic fistula following pancreatoduodenectomy. Evaluation of different surgical approaches in the management of pancreatic stump. Literature review. 71
Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis 70
Clinical management of advanced gastric cancer: Role of new molecular drugs. 70
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass 70
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer 70
TRASTUZUMAB RESISTANCE IN BREAST CANCER 70
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer 68
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 68
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review. 67
Farmacogenomica e cancro colorettale 66
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study 64
CD 26-positive/CD 326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence 64
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) 63
Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer. 63
Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome 62
Treatment of gastric cancer. 62
Phosphatidylinositol 3-kinase (PI3Ka)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells 62
Different Biomarkers address different colorectal cancer stem cell populations: who's the killer? 61
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients 59
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer 59
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors 58
Chemoradiotherapy as adjuvant treatment of gastric cancer 58
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival 58
Naples Prognostic Score, Based on Nutritional and Inflammatory Status, is an Independent Predictor of Long-term Outcome in Patients Undergoing Surgery for Colorectal Cancer 58
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells 57
Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report. 57
Cardiotossicità da antracicline: attualità e prospettive 57
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 57
The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery. 56
Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator 56
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment 56
Behavior of circulating CD4+CD25+FOXP3* regulatory T cells in colon cancer patients undergoing surgery 56
Indocyanine Green Fluorescence Imaging-Guided Surgery in Primary and Metastatic Liver Tumors 56
Fluorescence-Guided Surgery in the Combined Treatment of Peritoneal Carcinomatosis from Colorectal Cancer: Preliminary Results and Considerations 56
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 56
Determination of molecular marker expression can predict clinical outcome in colon carcinomas 55
Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion 55
Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracyclina-induced cardiotoxicity (review) 55
Post- operative xelox and chemoradiation in stage III-IV radically resected gastric cancer patients: preliminary results of a pilot study. 55
Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience 55
Integrated therapy in localized gastric cancer: targeted and tailored approach. 54
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors. A phase I study 54
Ventricular repolarization time indexes following anthracycline treatment 54
Conversion chemotherapy followed by epatic resection in colorectal cancer with initially unresectable liver-limited metastases 54
The over-the-scope-clip (OTSC) system is effective in the treatment of chronic esophago-jejunal anastomotic leakage 54
Complete response to preoperative chemoradiation and survival in esophageal cancer : a pooled analysis of three singe-institution phase II trials. 54
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next generation sequencing: findings from the CAPRI-GOIM trial. 53
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC). 53
Il linfoma primitivo della parotide: una localizzazione infrequente 53
Il trattamento delle neoplasie polmonari nell’anziano 53
Serum interleukin-10 is an independent prognostic factor in advanced solid tumors 52
Neo-adjuvant and adjuvant chemotherapy of gastric cancer 52
Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients 52
Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis 52
Adult Wilms' tumor: a case report 52
Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial 52
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies 51
Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery 51
Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: A phase II study 51
Carcinoma dell'esofago 51
Serum vascular endothelial growth factor (VEGF)levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer 50
Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery 50
Targeting EGFR in Pancreatic Cancer Treatment. 50
Metachronous Gastrointestinal Stromal Tumors (Gists) or relapse of the primary tumor ? A challenging case of multiple Gists in an elderly patient 50
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs 50
Cetuximab in the treatment of colorectal cancer. 49
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis 49
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis 49
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 49
Preoperative chemo-radiotherapy for carcinoma of the esophagus 48
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group 48
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients 48
A true splenic cyst producing carbohydrate antigen 19-9 and cancer antigens 50 and 125, but not interleukin 10 48
Propensity score-matched comparison between complete mesocolic excision and classic right hemicolectomy for colon cancer 48
Novel investigational drugs for gastric cancer 47
Prognostic value of p27, p53, and vascular endothelial growth factor in Dukes’ A and B colon cancer patients undergoing potentially curative surgery 47
The new European gold standard treatment for rectum cancer 47
Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma 47
Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy 47
Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions 47
Adjuvant chemotherapy of gastric cancer: which regimen? 46
Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer: A phase II study 46
Pancreatic neuroendocrine tumors: Nosography, management and treatment 46
Atypycal presentation of Merkel cell carcinoma positive to polyomavirus DNA detection: experience from a single center 45
Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers ? A prospective study. 45
Emergenze ematologiche nel paziente neoplastico 45
Impact of total fundoplication on esophageal transit: analysis by combined multichannel intraluminal impedance and manometry. 45
MEK inhibitor as a single agent and in combination with everolimus or sorafenib in a panel of colorectal cancer cell lines: implication for multitargeted approach 45
Beyond bevacizumab: new anti-VEGF strategies in colorectal cancer. 45
Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score. 45
Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines 44
Totale 5.751
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.180
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019344 0 0 0 0 0 0 0 0 0 0 314 30
2019/20201.128 213 173 28 14 156 28 210 81 91 61 49 24
2020/20211.387 128 17 153 85 257 16 196 141 13 165 146 70
2021/20221.171 104 3 17 19 412 7 19 39 42 55 114 340
2022/20232.682 321 45 37 206 305 207 15 159 1.290 11 45 41
2023/2024790 85 33 48 85 351 127 9 21 10 18 3 0
Totale 8.849